Pamela Esposito
Director at Kymera Therapeutics, Inc. (KYMR)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $3.1M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Mar 20SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 7001,800 held (−28%) | $77.71 | $54K | +44.6% |
| Mar 20SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 6001,200 held (−33%) | $79.24 | $48K | +41.8% |
| Mar 20SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 1,200 | $79.94 | $96K | +40.6% |
| Feb 20SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 1,900600 held (−76%) | $87.06 | $165K | +29.1% |
| Feb 20SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 600 | $88.10 | $53K | +27.6% |
| Jan 20SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 4005,100 held (−7%) | $66.68 | $27K | +68.6% |
| Jan 20SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 4,900200 held (−96%) | $67.99 | $333K | +65.3% |
| Jan 20SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 200 | $68.52 | $14K | +64.0% |
| Dec 17SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 14,50513,058 held (−53%) | $81.56 | $1.2M | +37.8% |
| Dec 17SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 7,9595,099 held (−61%) | $82.34 | $655K | +36.5% |
| Dec 17SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 4,0991,000 held (−80%) | $83.45 | $342K | +34.7% |
| Dec 17SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 1,000 | $84.07 | $84K | +33.7% |
- Sell
Director Pamela Esposito sold $54K of KYMR at $77.71 — cuts the stake by 28%; pre-scheduled 10b5-1 plan sale.
- Sell
Director Pamela Esposito sold $48K of KYMR at $79.24 — cuts the stake by 33%; pre-scheduled 10b5-1 plan sale.
- Sell
Director Pamela Esposito sold $96K of KYMR at $79.94 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Pamela Esposito sold $165K of KYMR at $87.06 — cuts the stake by 76%; pre-scheduled 10b5-1 plan sale.
- Sell
Director Pamela Esposito sold $53K of KYMR at $88.10 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Pamela Esposito sold $27K of KYMR at $66.68 — pre-scheduled 10b5-1 plan sale.